Health-care companies ticked up amid deal activity.
Swiss drug giant Roche Holding agreed to buy California-based biotechnology company Carmot Therapeutics for up to $3.1 billion, the latest major drug maker to seek entry to the booming niche of obesity and diabetes products.
Supreme Court justices weighed arguments on an agreement regarding Purdue Pharma's promotion of the addictive painkiller OxyContin in which survivors would receive timely compensation in exchange for granting the wealthy Sackler family immunity from future civil lawsuits.
Jennifer Taubert, head of Johnson & Johnson's pharmaceuticals unit, and J&J Chief Financial Officer Joseph Wolk are leading contenders to succeed Chief Executive Officer Joaquin Duato when the time comes, The Wall Street Journal reported.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
12-04-23 1825ET
